DK0696194T3 - Anvendelse af indolderivater som 5HT1-antagonister - Google Patents

Anvendelse af indolderivater som 5HT1-antagonister

Info

Publication number: DK0696194T3
Authority: DK; Denmark
Prior art keywords: antagonists; indole derivatives; indole; derivatives
Prior art date: 1993-04-27

Application number

DK94912048T

Other languages

Danish (da)

English (en)

Inventor

John Eugene Macor

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-27

Filing date

1994-04-26

Publication date

2002-10-07

1994-04-26 Application filed by Pfizer filed Critical Pfizer

2002-10-07 Application granted granted Critical

2002-10-07 Publication of DK0696194T3 publication Critical patent/DK0696194T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

DK94912048T 1993-04-27 1994-04-26 Anvendelse af indolderivater som 5HT1-antagonister DK0696194T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US5393093A	1993-04-27	1993-04-27
PCT/IB1994/000079 WO1994025023A1 (en)	1993-04-27	1994-04-26	Use of indole derivatives as 5ht1 antagonists

Publications (1)

Publication Number	Publication Date
DK0696194T3 true DK0696194T3 (da)	2002-10-07

Family

ID=21987528

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94912048T DK0696194T3 (da)	1993-04-27	1994-04-26	Anvendelse af indolderivater som 5HT1-antagonister

Country Status (29)

Country	Link
EP (1)	EP0696194B1 (es)
JP (1)	JP2922307B2 (es)
KR (1)	KR960701636A (es)
CN (3)	CN1121689A (es)
AP (1)	AP486A (es)
AT (1)	ATE222492T1 (es)
AU (1)	AU689469B2 (es)
BG (1)	BG61898B1 (es)
BR (1)	BR9406435A (es)
CA (1)	CA2161533C (es)
CO (1)	CO4230093A1 (es)
CZ (1)	CZ290416B6 (es)
DE (1)	DE69431201T2 (es)
DK (1)	DK0696194T3 (es)
ES (1)	ES2180573T3 (es)
HU (1)	HU222488B1 (es)
IL (1)	IL109376A (es)
MX (1)	MX9403088A (es)
NO (1)	NO308236B1 (es)
NZ (1)	NZ263614A (es)
OA (1)	OA10189A (es)
PL (1)	PL175156B1 (es)
PT (1)	PT696194E (es)
RO (1)	RO117760B1 (es)
RU (1)	RU2132683C1 (es)
SG (1)	SG43951A1 (es)
SK (1)	SK283353B6 (es)
WO (1)	WO1994025023A1 (es)
ZA (1)	ZA942805B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5578612A (en) *	1990-10-15	1996-11-26	Pfizer Inc.	Indole derivatives
US5559246A (en) *	1990-10-15	1996-09-24	Pfizer Inc.	Indole derivatives
US5607951A (en) *	1990-10-15	1997-03-04	Pfizer Inc	Indole derivatives
US5545644A (en) *	1990-10-15	1996-08-13	Pfizer Inc.	Indole derivatives
US5559129A (en) *	1990-10-15	1996-09-24	Pfizer Inc	Indole derivatives
CZ59996A3 (en) *	1993-08-31	1996-06-12	Pfizer	5-arylindole derivatives per se and for treating diseases, intermediates for their preparation and pharmaceutical compositions based thereon
GB9417310D0 (en) *	1994-08-27	1994-10-19	Pfizer Ltd	Therapeutic agents
PT804433E (pt) *	1994-10-12	2002-12-31	Pfizer Res & Dev	Derivado de indole para o tratamento da enxaqueca
GB9424471D0 (en) *	1994-12-03	1995-01-18	Pfizer Ltd	Treatment of emesis
GB9510223D0 (en) *	1995-05-20	1995-07-19	Pfizer Ltd	Therapeutic agent
US5945118A (en) *	1995-09-29	1999-08-31	Pfizer Inc	Indole derivative for the treatment of migraine
US5773015A (en) *	1996-11-27	1998-06-30	Elizabeth Arden Co., Division Of Conopco, Inc.	Method for controlling skin oils and grease
GB9706089D0 (en) *	1997-03-24	1997-05-14	Scherer Ltd R P	Pharmaceutical composition
US5994352A (en) *	1998-11-13	1999-11-30	Pfizer Inc.	5-arylindole derivatives
ES2199086B1 (es) *	2002-07-31	2005-06-01	Cepa Schwarz Pharma Sl	Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
IL295374A (en) *	2020-02-04	2022-10-01	Mindset Pharma Inc	3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE9190141U1 (de) *	1990-10-15	1993-07-15	Pfizer Inc., New York, N.Y.	Indolderivate
GB9102579D0 (en) *	1991-01-24	1991-03-27	Glaxo Group Ltd	Compositions
GB9103770D0 (en) *	1991-02-22	1991-04-10	Glaxo Group Ltd	Chemical compounds

1994
- 1994-04-07 AP APAP/P/1994/000633A patent/AP486A/en active
- 1994-04-21 IL IL10937694A patent/IL109376A/xx not_active IP Right Cessation
- 1994-04-22 ZA ZA942805A patent/ZA942805B/xx unknown
- 1994-04-25 CO CO94016790A patent/CO4230093A1/es unknown
- 1994-04-26 JP JP6524076A patent/JP2922307B2/ja not_active Expired - Fee Related
- 1994-04-26 ES ES94912048T patent/ES2180573T3/es not_active Expired - Lifetime
- 1994-04-26 SG SG1996006766A patent/SG43951A1/en unknown
- 1994-04-26 EP EP94912048A patent/EP0696194B1/en not_active Expired - Lifetime
- 1994-04-26 CN CN94191935A patent/CN1121689A/zh active Pending
- 1994-04-26 RU RU95120093/14A patent/RU2132683C1/ru not_active IP Right Cessation
- 1994-04-26 CN CNA011046600A patent/CN1509713A/zh active Pending
- 1994-04-26 CN CNA021506892A patent/CN1515252A/zh active Pending
- 1994-04-26 AT AT94912048T patent/ATE222492T1/de not_active IP Right Cessation
- 1994-04-26 HU HU9503089A patent/HU222488B1/hu not_active IP Right Cessation
- 1994-04-26 PL PL94311266A patent/PL175156B1/pl unknown
- 1994-04-26 BR BR9406435A patent/BR9406435A/pt not_active Application Discontinuation
- 1994-04-26 RO RO95-01860A patent/RO117760B1/ro unknown
- 1994-04-26 CA CA002161533A patent/CA2161533C/en not_active Expired - Fee Related
- 1994-04-26 PT PT94912048T patent/PT696194E/pt unknown
- 1994-04-26 AU AU64360/94A patent/AU689469B2/en not_active Ceased
- 1994-04-26 SK SK1332-95A patent/SK283353B6/sk unknown
- 1994-04-26 DE DE69431201T patent/DE69431201T2/de not_active Expired - Fee Related
- 1994-04-26 NZ NZ263614A patent/NZ263614A/en unknown
- 1994-04-26 KR KR1019950704678A patent/KR960701636A/ko not_active Ceased
- 1994-04-26 DK DK94912048T patent/DK0696194T3/da active
- 1994-04-26 WO PCT/IB1994/000079 patent/WO1994025023A1/en not_active Ceased
- 1994-04-26 CZ CZ19952802A patent/CZ290416B6/cs not_active IP Right Cessation
- 1994-04-27 MX MX9403088A patent/MX9403088A/es unknown
1995
- 1995-10-25 BG BG100093A patent/BG61898B1/bg unknown
- 1995-10-26 NO NO954287A patent/NO308236B1/no not_active IP Right Cessation
- 1995-10-27 OA OA60728A patent/OA10189A/en unknown

Also Published As

Publication number	Publication date
HUT73670A (en)	1996-09-30
HU222488B1 (hu)	2003-07-28
DE69431201T2 (de)	2002-12-05
EP0696194A1 (en)	1996-02-14
CN1121689A (zh)	1996-05-01
AU689469B2 (en)	1998-04-02
SK133295A3 (en)	1997-01-08
AP486A (en)	1996-04-16
ATE222492T1 (de)	2002-09-15
CA2161533A1 (en)	1994-11-10
BG61898B1 (bg)	1998-09-30
JPH08504829A (ja)	1996-05-28
AP9400633A0 (en)	1994-04-30
KR960701636A (ko)	1996-03-28
OA10189A (en)	1996-12-18
MX9403088A (es)	1997-02-28
CO4230093A1 (es)	1995-10-19
CN1509713A (zh)	2004-07-07
CA2161533C (en)	1998-08-04
BR9406435A (pt)	1996-01-09
CZ9502802A3 (en)	1996-04-17
RU2132683C1 (ru)	1999-07-10
HU9503089D0 (en)	1995-12-28
EP0696194B1 (en)	2002-08-21
CN1515252A (zh)	2004-07-28
WO1994025023A1 (en)	1994-11-10
NO954287D0 (no)	1995-10-26
PL311266A1 (en)	1996-02-05
SG43951A1 (en)	1997-11-14
PL175156B1 (pl)	1998-11-30
BG100093A (bg)	1996-04-30
CZ290416B6 (cs)	2002-07-17
NZ263614A (en)	1998-02-26
IL109376A (en)	2000-10-31
AU6436094A (en)	1994-11-21
IL109376A0 (en)	1994-07-31
SK283353B6 (sk)	2003-06-03
ES2180573T3 (es)	2003-02-16
DE69431201D1 (de)	2002-09-26
JP2922307B2 (ja)	1999-07-19
NO954287L (no)	1995-10-26
PT696194E (pt)	2002-11-29
NO308236B1 (no)	2000-08-21
RO117760B1 (ro)	2002-07-30
ZA942805B (en)	1995-10-23

Publication	Publication Date	Title
DK0591280T3 (da)	1999-02-15	Anvendelse af tetrahydrocarbazolderivater som 5HT1-receptoragonister
DK0630376T3 (da)	1999-06-23	Kondenserede indolderivater som 5-HT4-receptorantagonister
FI960840A7 (fi)	1996-02-23	Indolijohdannaisia tromboksaani-A2-antagonisteina
DK0393936T3 (da)	1995-06-26	3-substituerede 2-oxindolderivater som antiinflammatoriske midler
FI960399A7 (fi)	1996-01-29	Perhydroisoindolijohdannaisia P-aineen antagonisteina
DK0516349T3 (da)	1995-11-06	2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
NO992725D0 (no)	1999-06-04	6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
DK0696194T3 (da)	2002-10-07	Anvendelse af indolderivater som 5HT1-antagonister
FI961628A0 (fi)	1996-04-12	Indolijohdannaisia NMDA-antagonisteina
NO960371D0 (no)	1996-01-29	Piperazinderivater som ter
NO974043D0 (no)	1997-09-03	Indolderivater som EAA-antagonister
FI962969A0 (fi)	1996-07-25	Indolijohdannaisia 5-HT1:n agonisteina
DK0746979T3 (da)	2004-09-06	Anvendelse af pyrrolforbindelser som antibegroningsmidler
FI944727L (fi)	1994-10-07	Indolijohdannaisia 5-HT1:n kaltaisina agonisteina
NO985970L (no)	1998-12-18	Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
NO961333D0 (no)	1996-04-01	Nye pyrazolderivater som angiotensin-II-antagonister
FI951798A0 (fi)	1995-04-13	Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
LV10448A (lv)	1995-02-20	Piperazinilkamparsulfoniloksitocina antagonista aizvietotie amidu atvasinajumi
NO985972L (no)	1998-12-18	Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
FI943119A0 (fi)	1994-06-29	Heterosyklisellä renkaalla substituoituja bentsyyliamiinijohdannaisia retrovirusvastaisina yhdisteinä
FI960730A7 (fi)	1996-02-16	Indolijohdannaiset 5alfa-reduktaasi-1-inhibiittoreina
DK0944601T3 (da)	2003-06-10	Heterocykliske quanidinylaminoforbindelser som alfa-2-adrenoceptoragonister
NO20021249L (no)	2002-05-10	Tienoisoksazolfenoksyusubstituerte etyl- og propylderivater anvendbare som D4antagonister
DK0938330T3 (da)	2002-05-27	Anvendelse af LH-RH antagonister som diagnostisk middel
DK0861252T3 (da)	2000-06-19	Naphthamidderivater af 3-beta-amino-azabicyclooctan eller -nonan som antipsykotiske midler